What is NDC 0093-7272?

0093-7272 is the product NDC for Pioglitazone, Pioglitazone hydrochloride 30 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pioglitazone?

43 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pioglitazone NDC 0093-7272 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-7272Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-7272Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0093-7272-05	0009372720500093727205	500 TABLET in 1 BOTTLE (0093-7272-05)Marketed from Feb 4, 2015
0093-7272-56	0009372725600093727256	30 TABLET in 1 BOTTLE (0093-7272-56)Marketed from Apr 22, 2015
0093-7272-98	0009372729800093727298	90 TABLET in 1 BOTTLE (0093-7272-98)Marketed from Jun 3, 2015

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pioglitazone
Generic name (nonproprietary): pioglitazone
Active ingredients: Pioglitazone hydrochloride — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077210
Marketing start: Feb 4, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Peroxisome Proliferator-activated Receptor alpha Agonists (Mechanism)Peroxisome Proliferator-activated Receptor gamma Agonists (Mechanism)Thiazolidinediones (Chemical structure)
Identifiers: Product ID 0093-7272_4552ad10-d451-4a09-8640-bf7a5d9cc5d9SPL ID 4552ad10-d451-4a09-8640-bf7a5d9cc5d9SPL set ID c5c81c67-90cf-4e64-acb5-58b0358fa742RxCUI 312440, 312441, 317573UNII JQT35NPK6C
Pharmacologic class: Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093727205 followed by a unit qualifier and the quantity

Package 00093-7272-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2021. This label includes a boxed warning.

Indications (excerpt from the label)

Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [ see Clinical Studies ( 14 ) ]. Important Limitations of Use Pioglitazone tablets exert their antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [ see Warnings and Precautions ( 5.3 ) ]. Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-7272

What is NDC 0093-7272?: 0093-7272 is the product NDC for Pioglitazone, Pioglitazone hydrochloride 30 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pioglitazone.
What is the active ingredient?: Pioglitazone hydrochloride.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pioglitazone?: 43 other product NDCs are listed under this name. See all Pioglitazone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pioglitazone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4187	68788-4187-0168788-4187-0368788-4187-06+1 more
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	American Health Packaging	60687-905	60687-0905-21
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	AvKARE	42291-959	42291-0959-3042291-0959-90
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	AvKARE	42291-960	42291-0960-3042291-0960-90
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	AvKARE	42291-961	42291-0961-3042291-0961-50
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	NorthStar RxLLC	16714-645	16714-0645-0116714-0645-0216714-0645-03
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	NorthStar RxLLC	16714-646	16714-0646-0116714-0646-0216714-0646-03
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	NorthStar RxLLC	16714-647	16714-0647-0116714-0647-0216714-0647-03
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	A-S Medication Solutions	50090-6412	50090-6412-0050090-6412-01
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	A-S Medication Solutions	50090-6873	50090-6873-0050090-6873-01

All 44 Pioglitazone NDCs

Other NDCs under ANDA 077210

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077210
Product	Strength	Form · route	Labeler	Product NDC
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7271
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7273
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	AvKARE	42291-959
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	AvKARE	42291-960
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	AvKARE	42291-961
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	American Health Packaging	60687-391
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	American Health Packaging	60687-905
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2373
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5245
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	Bryant Ranch Prepack	71335-1333